KemPharm Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.51 |
Market Cap |
$45.63 M |
Shares Outstanding |
28.52 M |
Public Float |
23.39 M |
Address |
1180 Celebration Boulevard Celebration Florida 34747 United States |
Employees | - |
Website | http://www.kempharm.com |
Updated | 07/08/2019 |
KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. |